Lipid alterations and endothelial dysfunction are associated with multiple sclerosis pathophysiology.

Area of Science:

• Neuroimmunology
• Vascular Biology
• Metabolic Disorders

Background:

• Multiple sclerosis (MS) traditionally viewed as CNS-restricted.
• Emerging evidence suggests systemic factors contribute to MS pathophysiology.
• Understanding systemic involvement is crucial for comprehensive MS management.

Purpose of the Study:

• To investigate the relationship between lipid profile abnormalities and endothelial dysfunction in MS patients.
• To explore associations between these vascular markers and MS disease severity.
• To determine if systemic alterations differentiate MS patients from healthy individuals.

Main Methods:

• Assessed intima-media thickness (IMT) and endothelial activation markers (E-selectin, P-selectin).
• Measured serum lipid parameters: total cholesterol (TC), HDL-C, LDL-C, non-HDL-C, and triglycerides (TG).
• Correlated vascular and lipid markers with clinical data (EDSS, disease duration).

Main Results:

• MS patients exhibited altered lipid profiles linked to endothelial dysfunction and IMT.
• Soluble E-selectin, TC, HDL-C, and LDL-C levels differed significantly between MS patients and controls.
• Lower IMT in MS patients, despite higher BMI and altered lipids, suggests non-atherosclerotic vascular remodeling.
• Lipid and endothelial markers associated with Expanded Disability Status Scale (EDSS) scores and disease duration.

Conclusions:

• Multiple sclerosis is associated with systemic vascular and lipid alterations extending beyond the CNS.
• These systemic changes correlate with disease severity and endothelial dysfunction.
• Findings highlight the need to consider systemic factors in MS pathophysiology and treatment.